Market Cap 6.18B
Revenue (ttm) 10.90M
Net Income (ttm) -322.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,956.88%
Debt to Equity Ratio 0.00
Volume 3,793,800
Avg Vol 3,054,944
Day's Range N/A - N/A
Shares Out 128.65M
Stochastic %K 19%
Beta 0.99
Analysts Strong Sell
Price Target $67.11

Company Profile

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs). Its AOC platform is designed to combine the specificity of monoclonal antibodies with the precision of RNA therapeutics to target the root cause of diseases previously untreatable with such therapeutics. The company's pipeline has three programs in registrational clinical trials, such as Delpacibart etedesiran, which is in Phase 3 development stag...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 401 7900
Address:
10578 Science Center Drive, Suite 125, San Diego, United States
dgbio
dgbio Sep. 11 at 3:50 AM
$RNA About a year ago there was a rumor about Mirum being approached by Sobi and there was some up and down trading because of it. Mirum stays independent, its SP has doubled and it's likely above Sobi's offering. Who needs Novartis with their offer, say, of 70, when Avidity has a good chance to hit 100 on its own in a year?
0 · Reply
Arcides
Arcides Sep. 11 at 12:59 AM
0 · Reply
healthcareguru
healthcareguru Sep. 11 at 12:19 AM
$RNA so this is down 23% on 9% dilution ahead of. A massive revenue inflection?? Yeah…EASY BUY.
0 · Reply
skeezbag
skeezbag Sep. 10 at 11:46 PM
$ARWR see what happens when the cucks at leerink think your stock is a buy $RNA ....they help lead an offering and shove it down shareholders throats This post is nothing negative against rna
1 · Reply
dgbio
dgbio Sep. 10 at 11:13 PM
$RNA just did what every biotech normally does: raises cash after a good news to have at least two years of runway (keeping in mind three potential launches). In the highly volatile political environment, it's a must. Talks with Novartis were reported as early-stage and should not influence fundraising at all unless the company is ready to sell itself at fire-sale price.
0 · Reply
DHolliday
DHolliday Sep. 10 at 10:52 PM
$RNA Any guesses on the offering price ?
0 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 10:52 PM
$RNA Oh boy you were wrong again and again. I love your enthusiasm, lol
1 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 10:12 PM
0 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 10:02 PM
$RNA no wondee
0 · Reply
TheHookingBull
TheHookingBull Sep. 10 at 9:58 PM
$RNA how does this impact the potential buyout?
1 · Reply
Latest News on RNA
Avidity Biosciences Honors Rare Disease Day®

Feb 29, 2024, 12:00 PM EST - 1 year ago

Avidity Biosciences Honors Rare Disease Day®


dgbio
dgbio Sep. 11 at 3:50 AM
$RNA About a year ago there was a rumor about Mirum being approached by Sobi and there was some up and down trading because of it. Mirum stays independent, its SP has doubled and it's likely above Sobi's offering. Who needs Novartis with their offer, say, of 70, when Avidity has a good chance to hit 100 on its own in a year?
0 · Reply
Arcides
Arcides Sep. 11 at 12:59 AM
0 · Reply
healthcareguru
healthcareguru Sep. 11 at 12:19 AM
$RNA so this is down 23% on 9% dilution ahead of. A massive revenue inflection?? Yeah…EASY BUY.
0 · Reply
skeezbag
skeezbag Sep. 10 at 11:46 PM
$ARWR see what happens when the cucks at leerink think your stock is a buy $RNA ....they help lead an offering and shove it down shareholders throats This post is nothing negative against rna
1 · Reply
dgbio
dgbio Sep. 10 at 11:13 PM
$RNA just did what every biotech normally does: raises cash after a good news to have at least two years of runway (keeping in mind three potential launches). In the highly volatile political environment, it's a must. Talks with Novartis were reported as early-stage and should not influence fundraising at all unless the company is ready to sell itself at fire-sale price.
0 · Reply
DHolliday
DHolliday Sep. 10 at 10:52 PM
$RNA Any guesses on the offering price ?
0 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 10:52 PM
$RNA Oh boy you were wrong again and again. I love your enthusiasm, lol
1 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 10:12 PM
0 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 10:02 PM
$RNA no wondee
0 · Reply
TheHookingBull
TheHookingBull Sep. 10 at 9:58 PM
$RNA how does this impact the potential buyout?
1 · Reply
stockanalysis_
stockanalysis_ Sep. 10 at 9:47 PM
After Hours Losers: $RBNE $ILAG $RNA $LNKS $QMCO Bookmark this page: https://stockanalysis.com/markets/afterhours/losers/?ref=saveontrading
0 · Reply
Willdowdell
Willdowdell Sep. 10 at 9:37 PM
$RNA wtf? Why do these guys keep on diluting? They do not have liquidity issues! Why?
1 · Reply
Doggyzilla
Doggyzilla Sep. 10 at 9:07 PM
$RNA jokers! Aka c11nts
0 · Reply
wwmeinc
wwmeinc Sep. 10 at 9:04 PM
$RNA ....I am calc. around a 12.5% dilution of the shares...using 129,622,000 s/o....$575M.... Gives around 16,100,000 shrs to sell if $35.75 is the worse case....staying upbeat for the future though, no matter...glta
0 · Reply
wwmeinc
wwmeinc Sep. 10 at 8:48 PM
$RNA ....I was not expecting a raise with the ~$1.2 Billion on-hand for sure...furthest thing from my mindset here....feeding the ducks comes to mind though.....shareholders now carrying the burden to allow a 'bidder or two' to grab all, including all the cash in the kitty(I am still not ready to toss the rumour out, just yet....I realize I am most likely now in the minority camp but this is the mkt....we place our bets and take the hits sometimes)....Any haircut tonight might allow any suitor to increase their holdings if they so wish...and if nobody shows up, so be it...~$35.50....the $10 swing is very manageable...just my thoughts...good trading and glta. https://stockanalysis.com/stocks/rna/ratings/
0 · Reply
Hello_AI
Hello_AI Sep. 10 at 8:29 PM
$RNA august rise september fall ..!!
0 · Reply
SenefAS
SenefAS Sep. 10 at 8:25 PM
$IBB $NVS $RNA $TRML $XBI I have told you yesterday good bye Avidity…
0 · Reply
MadHatterTrades74
MadHatterTrades74 Sep. 10 at 8:15 PM
$RNA Yeah, this one confused me. I can understand a direct offering, but not a public offering when you have over $1B liquidity. Their quarterly burn rate must be Massive
1 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 8:13 PM
$RNA @Fairvalue10
1 · Reply
TheGunnerAB
TheGunnerAB Sep. 10 at 8:10 PM
$RNA i told you guys and called names
1 · Reply
RonIsWrong
RonIsWrong Sep. 10 at 8:09 PM
$RNA Avidity Biosciences Announces $500M Proposed Public Offering Of Common Stock so much for a buyout
1 · Reply
JarvisFlow
JarvisFlow Sep. 10 at 4:38 PM
Needham has adjusted their stance on Avidity Biosciences ( $RNA ), setting the rating to Buy with a target price of 60 → 65.
0 · Reply